THERAtRAME
PrivateLast Round
Seed
Sep 5, 2022
Total Funding Raised
$4.46M
Company Overview
THERAtRAME is a biotechnology company that develops first-in-class small molecule therapeutics targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers.
Sector
Healthcare & Life Sciences
Verticals
Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
THERAtRAME Comparables
Compare THERAtRAME with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EPICS Therapeutics | 31% |
THERAtRAME Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2022 |
Key People
Founding team and executive leadership
THERAtRAME Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Seed |
| Gesval | Seed |
| QBIC III Fund | Seed |
| Société Régionale d'Investissement de Wallonie | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2026
Grew 60% QoQ, from 10 to 16 employees.
- Jun 5, 2024
Grew 27% QoQ from 11 to 14 employees.
THERAtRAME Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about THERAtRAME's valuation, stock price, and market status.
Is THERAtRAME a public or private company?
THERAtRAME is a private company.
What is the current stock price of THERAtRAME?
THERAtRAME is a private company with no public stock price. Caplight tracks THERAtRAME's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is THERAtRAME worth (valuation)?
Valuation information for THERAtRAME is not publicly available.
Can I buy THERAtRAME stock?
THERAtRAME shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was THERAtRAME's last funding round?
THERAtRAME's most recent funding round was Seed on September 5, 2022.
Who are the main investors in THERAtRAME?
Key investors in THERAtRAME include QBIC III Fund.
Will THERAtRAME IPO soon?
No public IPO plans have been announced for THERAtRAME.
How can I track THERAtRAME secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor THERAtRAME's secondary market activity and sign up for updates.